Published in Life Sci on April 01, 1977
Muscarinic cholinergic receptors in murine lymphocytes: demonstration by direct binding. Proc Natl Acad Sci U S A (1978) 0.90
Tetrodotoxin-sensitive Na+ channels and muscarinic and purinergic receptors identified in human erythroid progenitor cells and red blood cell ghosts. Proc Natl Acad Sci U S A (2004) 0.82
Personality factors predisposing to depression correlate significantly negatively with M1-muscarinic and beta-adrenergic receptor densities on blood cells. Eur Arch Psychiatry Neurol Sci (1988) 0.75
Colorimetric Estimation of Succinic Dehydrogenase by Triphenyltetrazolium Chloride. Science (1949) 4.77
Properties of an ATP-binding protein isolated from membranes of nerve endings. Biochim Biophys Acta (1968) 1.59
Influence of sulfhydryl reagents and heavy metals on the functional state of the muscarinic acetylcholine receptor in rat brain. Mol Pharmacol (1978) 1.33
Activation, inactivation, and desensitization of acetylcholine receptor channel complex detected by binding of perhydrohistrionicotoxin. Proc Natl Acad Sci U S A (1980) 1.28
Phencyclidine interactions with the ionic channel of the acetylcholine receptor and electrogenic membrane. Proc Natl Acad Sci U S A (1980) 1.11
Sites of action of phencyclidine. II. Interaction with the ionic channel of the nicotinic receptor. Mol Pharmacol (1980) 1.09
Selective blockade of NMDA-activated channel currents may be implicated in learning deficits caused by lead. FEBS Lett (1990) 1.07
Purification of the opiate receptor from rat brain. Proc Natl Acad Sci U S A (1981) 1.04
Electrophysiological, behavioral, and chemical evidence for a noncholinergic, stereospecific site for nicotine in rat brain. J Neurosci Res (1978) 1.03
The anticonvulsant MK-801 interacts with peripheral and central nicotinic acetylcholine receptor ion channels. J Pharmacol Exp Ther (1990) 1.03
M3 muscarinic acetylcholine receptors regulate cytoplasmic myosin by a process involving RhoA and requiring conventional protein kinase C isoforms. J Biol Chem (1999) 1.01
Solubilization of the opiate receptor. Life Sci (1980) 1.00
Electrophysiological and biochemical studies on enhancement of desensitization by phenothiazine neuroleptics. Proc Natl Acad Sci U S A (1983) 0.96
Cocaine and phencyclidine inhibition of the acetylcholine receptor: analysis of the mechanisms of action based on measurements of ion flux in the millisecond-to-minute time region. Proc Natl Acad Sci U S A (1982) 0.95
[3H]Phencyclidine: a probe for the ionic channel of the nicotinic receptor. Proc Natl Acad Sci U S A (1980) 0.94
Inhibition of neuronal 5-HT uptake by ketamine, but not halothane, involves disruption of substrate recognition by the transporter. Neurosci Lett (1990) 0.94
Interrelationships between phosphates and calcium in bioelectric phenomena. Int Rev Neurobiol (1966) 0.93
Stereoselective muscarinic acetylcholine and opiate receptiors in human phagocytic leukocytes. Biochem Pharmacol (1980) 0.93
Sites and mechanisms for nicotine's action in the brain. Neurosci Biobehav Rev (1981) 0.93
Volatile anesthetics and glutamate activation of N-methyl-D-aspartate receptors. Biochem Pharmacol (1995) 0.92
Conversion between configurational states of the muscarinic receptor in rat brain. Eur J Pharmacol (1977) 0.91
Binding of semirigid nicotinic agonists to nicotinic and muscarinic receptors. Mol Pharmacol (1989) 0.91
Biochemical analysis of isolated bullfrog sarcolemma. Biochim Biophys Acta (1966) 0.91
The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. I. Agonist, desensitizing, and binding properties. Mol Pharmacol (1984) 0.90
Structural and stereochemical requirements for muscarinic receptor binding. Mol Pharmacol (1979) 0.90
Sites of action of phencyclidine. I. Effects on the electrical excitability and chemosensitive properties of the neuromuscular junction of skeletal muscle. Mol Pharmacol (1980) 0.90
Cocaine: mechanism of inhibition of a muscle acetylcholine receptor studied by a laser-pulse photolysis technique. Proc Natl Acad Sci U S A (1995) 0.90
Similarities in the binding sites of the muscarinic receptor and the ionic channel of the nicotinic receptor. Biochem Pharmacol (1980) 0.90
Nature of regional and chemically-induced differences in the binding properties of muscarinic acetylcholine receptors from rat brain. Neuropharmacology (1980) 0.89
Stimulation of phospholipase A2 and secretion of catecholamines from brain synaptosomes by potassium and A23187. J Neurochem (1983) 0.89
5,8-disubstituted indolizidines: a new class of noncompetitive blockers for nicotinic receptor-channels. Neurochem Res (1991) 0.89
Sites of action of phencyclidine. III. Interactions with muscarinic receptors. Mol Pharmacol (1980) 0.89
Solubilization of muscarinic acetylcholine receptors of bovine brain. Life Sci (1978) 0.89
Relationship of calcium and phosphates to bioelectric phenomena in the excitatory membrane. Perspect Biol Med (1965) 0.87
Clonidine protection from the toxicity of soman, an organophosphate acetylcholinesterase inhibitor, in the mouse. J Pharmacol Exp Ther (1986) 0.87
Interaction of gephyrotoxin and indolizidine alkaloids with the nicotinic acetylcholine receptor-ion channel complex of Torpedo electroplax. Neurochem Res (1986) 0.86
Immunocytochemistry of receptors using anti-idiotypic antibodies. Methods Enzymol (1989) 0.85
Cholinergic supersensitivity and decreased number of muscarinic receptors in atria from short-term diabetic rats. J Mol Cell Cardiol (1984) 0.85
Effects of adenosine and analogs on adenylate cyclase activity in cultured bovine aortic endothelial cells. Biochem Pharmacol (1990) 0.85
Ketamine inhibition of ligand binding to cholinergic receptors and ion channels. Eur J Pharmacol (1982) 0.84
Development of muscarinic cholinergic receptors in inbred strains of mice: identification of receptor heterogeneity and relation to audiogenic seizure susceptibility. Brain Res (1979) 0.84
Influence of N-ethylmaleimide on cholinoceptors and responses in longitudinal muscles from guinea-pig ileum. Br J Pharmacol (1982) 0.84
Regulation of [3H]perhydrohistrionicotoxin binding to Torpedo ocellata electroplax by effectors of the acetylcholine receptor. J Biol Chem (1981) 0.84
Clonidine protection from soman and echothiophate toxicity in mice. Life Sci (1986) 0.84
Changes in cholinergic parameters associated with failure of conotruncal septation in embryonic chick hearts after neural crest ablation. Circ Res (1985) 0.84
Involvement of protein kinase C and protein kinase A in the muscarinic receptor signalling pathways mediating phospholipase C activation, arachidonic acid release and calcium mobilisation. Cell Signal (1999) 0.83
Stereospecific 3H-nicotine binding to intact and solubilized rat brain membranes and evidence for its noncholinergic nature. Life Sci (1980) 0.83
Increased muscarinic responsiveness and decreased muscarinic receptor content in ileal smooth muscle in diabetes. J Pharmacol Exp Ther (1990) 0.82
Allosteric effect of gallamine on muscarinic cholinergic receptor binding: influence of guanine nucleotides and conformational state. Neurochem Res (1986) 0.82
Fluidity in hydrophobic protein regions of synaptic membranes. Eur J Biochem (1974) 0.82
Disruption of muscarinic receptor-G protein coupling is a general property of liquid volatile anesthetics. Neurosci Lett (1989) 0.82
Uptake and biliary excretion of Cu64 in rabbits in relation to blood ceruloplasmin. Proc Soc Exp Biol Med (1965) 0.82
Preparation and characterization of calcium-binding and other hydrophobic proteins from synaptic membranes. Biochim Biophys Acta (1976) 0.82
Decahydroquinoline alkaloids: noncompetitive blockers for nicotinic acetylcholine receptor-channels in pheochromocytoma cells and Torpedo electroplax. Neurochem Res (1991) 0.82
Interactions of tricyclic antidepressants with a synaptic ion channel. Life Sci (1981) 0.81
Early elevations of glycosidase, acid phosphatase, and acid proteolytic enzyme activity in denervated skeletal muscle. Exp Neurol (1974) 0.81
Preparation and spectroscopic characterization of molecular species of brain phosphatidylserines. Chem Phys Lipids (1980) 0.81
In vivo incorporation of l-[14C]serine into phospholipids and proteins of the subcellular fractions of developing rat brain. J Neurochem (1966) 0.81
Effect of colchicine and taxol on stimulation of G protein GTPase activity in anterior pituitary lobe of rats by gonadotrophin- and thyrotrophin-releasing hormones. J Reprod Fertil (1993) 0.81
Interactions of microtubule-active agents with nicotinic acetylcholine receptors. Relationship to their inhibition of catecholamine secretion by adrenal chromaffin cells. Mol Pharmacol (1985) 0.80
[3H]methylcarbamylcholine, a new radioligand for studying brain nicotinic receptors. Biochem Pharmacol (1986) 0.80
Interactions of bupivacaine with ionic channels of the nicotinic receptor. Electrophysiological and biochemical studies. Mol Pharmacol (1984) 0.80
Carbamate ester latentiation of physiologically active amines. J Med Chem (1970) 0.79
Altered muscarinic receptor properties and function in the heart in diabetes. J Pharmacol Exp Ther (1987) 0.79
Reversible conversion between affinity states for agonists of the muscarinic acetylcholine receptor from rat brain. Biochem Pharmacol (1979) 0.79
Pyrazole, an alcohol dehydrogenase inhibitor, has dual effects on N-methyl-D-aspartate receptors of hippocampal pyramidal cells: agonist and noncompetitive antagonist. J Pharmacol Exp Ther (1992) 0.79
Nicotinic pharmacology of anatoxin analogs. I. Side chain structure-activity relationships at peripheral agonist and noncompetitive antagonist sites. J Pharmacol Exp Ther (1991) 0.79
A novel agonist binding site on nicotinic acetylcholine receptors. J Recept Res (1993) 0.79
Isolation of a nicotine binding site from rat brain by affinity chromatography. Proc Natl Acad Sci U S A (1983) 0.79
Separation of brain phosphatidylserines according to degree of unsaturation by thin-layer chromatography. Anal Biochem (1976) 0.79
Stereospecific morphine adsorption to phosphatidyl serine and other membranous components of brain. Eur J Pharmacol (1975) 0.79
Expression and characterization of the rat alpha 4 beta 2 neuronal nicotinic cholinergic receptor in baculovirus-infected insect cells. J Neurosci Res (1996) 0.78
Precursors of cholinergic false transmitters: central effects on blood pressure and direct interactions with cholinergic receptors. Neuropharmacology (1988) 0.78
[3H]mecamylamine binding to rat brain membranes. Studies with mecamylamine and nicotine analogues. Biochem Pharmacol (1990) 0.78
Barrel rotation and prostration by vasopressin and nicotine in the vestibular cerebellum. Pharmacol Biochem Behav (1986) 0.78
Benzomorphan interactions with acetylcholine receptor complexes from Torpedo. Eur J Pharmacol (1983) 0.78
Adrenergic agonists protect against soman, an irreversible acetylcholinesterase inhibitor. Toxicol Lett (1987) 0.78
Biochemical studies on isolated nerve endings and other particulates of bullfrog brain. Biochim Biophys Acta (1967) 0.78
Antagonism of nicotine's action by cocaine analogs. Life Sci (1995) 0.78
Enhancement of stereospecific opiate binding to neural membranes by phosphatidyl serine. Eur J Pharmacol (1976) 0.78
Phospholipid changes in synaptic membranes by lipolytic enzymes and subsequent restoration of opiate binding with phosphatidylserine. Biochim Biophys Acta (1978) 0.78
Fentanyl and sufentanil inhibit agonist binding to 5-HT1A receptors in membranes from the rat brain. Neuropharmacology (1991) 0.77
Regulation of beta-adrenergic receptor density in the non-innervated and denervated embryonic chick heart. J Mol Cell Cardiol (1986) 0.77
The influence of isoflurane on the synaptic activity of 5-hydroxytryptamine. Neurochem Res (1990) 0.77
Substance P receptor desensitization in the dorsal horn: possible involvement of receptor-G protein complexes. Brain Res (1993) 0.77
Protection afforded by clonidine from the acute and chronic behavioral toxicity produced by the cholinesterase inhibitor soman. Neurotoxicol Teratol (1989) 0.77
Muscarinic acetylcholine receptors in chick heart: influence of heat and N-ethylmaleimide on receptor conformations and interactions with guanine nucleotide-dependent regulatory proteins. Neurosci Lett (1985) 0.77
Modulation of adenylate cyclase activity in cultured bovine pulmonary arterial endothelial cells. Effects of adenosine and derivatives. Biochem Pharmacol (1989) 0.77
Opioid receptor antagonist affinity ligands: 6 beta-bromoacetamido-6-desoxynaltrexone and 6 beta-thioglycolamido-6-desoxynaltrexone. Neurochem Res (1992) 0.77
Two classes of arginine vasopressin binding sites on rat brain membranes. Neurochem Res (1985) 0.77
Effects of halothane on high affinity agonist binding and guanine nucleotide sensitivity of muscarinic acetylcholine receptors from brainstem of rat. Neuropharmacology (1987) 0.77
Evidence for a noncholinergic site for nicotine's action in brain: psychopharmacological, electrophysiological and receptor binding studies. Arch Int Pharmacodyn Ther (1979) 0.77
Colchicine inhibits acetylcholine receptor stimulation of G protein GTPase activity in rat striatum. Pharmacol Toxicol (1991) 0.77
Behavioral effects of toxic doses of soman, an organophosphate cholinesterase inhibitor, in the rat: protection afforded by clonidine. Pharmacol Biochem Behav (1988) 0.77
Differential effect of sodium and potassium on calcium adsorption to stearic acid monolayers. Biochim Biophys Acta (1968) 0.77
Role of central biogenic amines on the protection afforded by clonidine against the toxicity of soman, an irreversible cholinesterase inhibitor. Toxicol Lett (1988) 0.77
Volatile anesthetics and NMDA receptors. Enflurane inhibition of glutamate-stimulated [3H]MK-801 binding and reversal by glycine. Neurosci Lett (1991) 0.77